1Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL. Neonatal streptoztocir-indueed rat model of Type 2 diabetes mellitus [ J ]. A glance Indian Journal of Pharmacology, 2004,36 (4) : 217- 221.
3Hill C, Flyvbjerg A, Gronbaek H, et al. The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology,2000, 141: 1196～1208.
4Iwano M, Kubo A, Nishino T, et al. Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int, 1996, 49: 1120～1126.
5Bertoluci MC , Schmid H , Lachat JJ , et al . Transforming growth factor-beta in the development of rat diabetic nephropathy. A 10-month study with insulin-reated rats. Nephron, 1996,74: 189～196.
6Hoshi S, Shu Y, Yoshida F, et al. Podocyte injury promotes progressive nephropathy inzucker diabetic fatty rats. Lab Invest,2002, 82 (1): 25～35.
7Lglesias-de la Gruz, Ziyadeh FN, Isono M, et al. Effects of high glucose and TGF-beta on the expression of collagen Ⅳ and vascular endothelial growth factor in mouse podocytes. Kidney Int, 2002, 62: 901～913.
8Gilbert RE, Cox A, Wu LL, et al. Expression of transforming growth factor-β1 and type Ⅳ collagen in the renal tubulointerstitium in experimental diabetes: Effects of ACE inhibition. Diabetes, 1998, 47: 414～422.
9Yamamoto T, Noble NA, Cohen Ah, et al. Expression of transforming growth factor-β isoforms in human giomerulardiseases. Kidney Int, 1996, 49 (2): 461～469.
10Ina K, Kitamura H, Tatsukawa S, et al. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy. Med Electron Microsc, 2002, 35: 87～96.
